171 related articles for article (PubMed ID: 22405007)
1. Structure of the human obesity receptor leptin-binding domain reveals the mechanism of leptin antagonism by a monoclonal antibody.
Carpenter B; Hemsworth GR; Wu Z; Maamra M; Strasburger CJ; Ross RJ; Artymiuk PJ
Structure; 2012 Mar; 20(3):487-97. PubMed ID: 22405007
[TBL] [Abstract][Full Text] [Related]
2. Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation.
Fazeli M; Zarkesh-Esfahani H; Wu Z; Maamra M; Bidlingmaier M; Pockley AG; Watson P; Matarese G; Strasburger CJ; Ross RJ
J Immunol Methods; 2006 May; 312(1-2):190-200. PubMed ID: 16690078
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of an octapeptide repeat of the prion protein in complex with a Fab fragment of the POM2 antibody.
Swayampakula M; Baral PK; Aguzzi A; Kav NN; James MN
Protein Sci; 2013 Jul; 22(7):893-903. PubMed ID: 23629842
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier Model.
Gonzalez-Carter D; Goode AE; Fiammengo R; Dunlop IE; Dexter DT; Porter AE
J Neuroendocrinol; 2016 Jun; 28(6):. PubMed ID: 27037668
[TBL] [Abstract][Full Text] [Related]
5. In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases.
Munikumar M; Krishna VS; Reddy VS; Rajeswari B; Sriram D; Rao MV
J Mol Graph Model; 2018 Jun; 82():20-36. PubMed ID: 29649778
[TBL] [Abstract][Full Text] [Related]
6. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1.
Baral PK; Wieland B; Swayampakula M; Polymenidou M; Rahman MH; Kav NN; Aguzzi A; James MN
Acta Crystallogr D Biol Crystallogr; 2012 Nov; 68(Pt 11):1501-12. PubMed ID: 23090399
[TBL] [Abstract][Full Text] [Related]
7. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S
Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody.
Ishchenko A; Wacker D; Kapoor M; Zhang A; Han GW; Basu S; Patel N; Messerschmidt M; Weierstall U; Liu W; Katritch V; Roth BL; Stevens RC; Cherezov V
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8223-8228. PubMed ID: 28716900
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Fab fragment of the anti-murine EGFR antibody 7A7 and exploration of its receptor binding site.
Talavera A; Mackenzie J; Garrido G; Friemann R; López-Requena A; Moreno E; Krengel U
Mol Immunol; 2011 Jul; 48(12-13):1578-85. PubMed ID: 21592580
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the TCR co-receptor CD8alphaalpha in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution.
Shore DA; Teyton L; Dwek RA; Rudd PM; Wilson IA
J Mol Biol; 2006 Apr; 358(2):347-54. PubMed ID: 16530222
[TBL] [Abstract][Full Text] [Related]
11. Atomic basis for the species-specific inhibition of αV integrins by monoclonal antibody 17E6 is revealed by the crystal structure of αVβ3 ectodomain-17E6 Fab complex.
Mahalingam B; Van Agthoven JF; Xiong JP; Alonso JL; Adair BD; Rui X; Anand S; Mehrbod M; Mofrad MR; Burger C; Goodman SL; Arnaout MA
J Biol Chem; 2014 May; 289(20):13801-9. PubMed ID: 24692540
[TBL] [Abstract][Full Text] [Related]
12. Atomistic mechanism of leptin and leptin-receptor association.
López-Hidalgo M; Caro-Gómez LA; Romo-Rodríguez R; Herrera-Zuñiga LD; Anaya-Reyes M; Rosas-Trigueros JL; Benítez-Cardoza CG
J Biomol Struct Dyn; 2023 Apr; 41(6):2231-2248. PubMed ID: 35075977
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
[TBL] [Abstract][Full Text] [Related]
14. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β.
Blech M; Peter D; Fischer P; Bauer MM; Hafner M; Zeeb M; Nar H
J Mol Biol; 2013 Jan; 425(1):94-111. PubMed ID: 23041424
[TBL] [Abstract][Full Text] [Related]
15. 20 years of leptin: insights into signaling assemblies of the leptin receptor.
Peelman F; Zabeau L; Moharana K; Savvides SN; Tavernier J
J Endocrinol; 2014 Oct; 223(1):T9-23. PubMed ID: 25063754
[TBL] [Abstract][Full Text] [Related]
16. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity.
Jeffrey PD; Strong RK; Sieker LC; Chang CY; Campbell RL; Petsko GA; Haber E; Margolies MN; Sheriff S
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10310-4. PubMed ID: 8234291
[TBL] [Abstract][Full Text] [Related]
17. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization.
Schmiedel J; Blaukat A; Li S; Knöchel T; Ferguson KM
Cancer Cell; 2008 Apr; 13(4):365-73. PubMed ID: 18394559
[TBL] [Abstract][Full Text] [Related]
18. Different binding modes of free and carrier-protein-coupled nicotine in a human monoclonal antibody.
Tars K; Kotelovica S; Lipowsky G; Bauer M; Beerli RR; Bachmann MF; Maurer P
J Mol Biol; 2012 Jan; 415(1):118-27. PubMed ID: 22079050
[TBL] [Abstract][Full Text] [Related]
19. Ob-stopping obesity, metabolic and immune-mediated disorders.
Matarese G; De Rosa V
Structure; 2012 Mar; 20(3):385-7. PubMed ID: 22404995
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
